Literature DB >> 21724447

Efficiency of hit generation and structural characterization in fragment-based ligand discovery.

Andreas Larsson1, Anna Jansson, Anders Åberg, Pär Nordlund.   

Abstract

Fragment-based ligand discovery constitutes a useful strategy for the generation of high affinity ligands with suitable physico-chemical properties to serve as drug leads. There is an increasing number of generic biophysical screening strategies established with the potential for accelerating the generation of useful fragment hits. Crystal structures of these hits can subsequently be used as starting points for fragment evolution to high affinity ligands. Emerging understanding of the efficiency and operative aspects of hit generation and structural characterization in FBLD suggests that this method should be well suited for academic ligand development of chemical tools and experimental therapeutics.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 21724447     DOI: 10.1016/j.cbpa.2011.06.008

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  14 in total

Review 1.  Three-dimensional structures in the design of therapeutics targeting parasitic protozoa: reflections on the past, present and future.

Authors:  Wim G J Hol
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-04-16       Impact factor: 1.056

2.  Plate-based diversity subset screening: an efficient paradigm for high throughput screening of a large screening file.

Authors:  Andrew S Bell; Joseph Bradley; Jeremy R Everett; Michelle Knight; Jens Loesel; John Mathias; David McLoughlin; James Mills; Robert E Sharp; Christine Williams; Terence P Wood
Journal:  Mol Divers       Date:  2013-04-05       Impact factor: 2.943

3.  Target-specific NMR detection of protein-ligand interactions with antibody-relayed 15N-group selective STD.

Authors:  Anasztázia Hetényi; Zsófia Hegedűs; Roberta Fajka-Boja; Éva Monostori; Katalin E Kövér; Tamás A Martinek
Journal:  J Biomol NMR       Date:  2016-11-24       Impact factor: 2.835

4.  Crystal packing modifies ligand binding affinity: the case of aldose reductase.

Authors:  Alexandra Cousido-Siah; Tatiana Petrova; Isabelle Hazemann; André Mitschler; Francesc X Ruiz; Eduardo Howard; Stephan Ginell; Cédric Atmanene; Alain Van Dorsselaer; Sarah Sanglier-Cianférani; Andrzej Joachimiak; Alberto Podjarny
Journal:  Proteins       Date:  2012-07-28

5.  Efficient Hit-to-Lead Searching of Kinase Inhibitor Chemical Space via Computational Fragment Merging.

Authors:  Grigorii V Andrianov; Wern Juin Gabriel Ong; Ilya Serebriiskii; John Karanicolas
Journal:  J Chem Inf Model       Date:  2021-11-11       Impact factor: 4.956

6.  Fragment screening of cyclin G-associated kinase by weak affinity chromatography.

Authors:  Elinor Meiby; Stefan Knapp; Jonathan M Elkins; Sten Ohlson
Journal:  Anal Bioanal Chem       Date:  2012-08-24       Impact factor: 4.142

7.  Dissecting fragment-based lead discovery at the von Hippel-Lindau protein:hypoxia inducible factor 1α protein-protein interface.

Authors:  Inge Van Molle; Andreas Thomann; Dennis L Buckley; Ernest C So; Steffen Lang; Craig M Crews; Alessio Ciulli
Journal:  Chem Biol       Date:  2012-10-26

8.  A binding hotspot in Trypanosoma cruzi histidyl-tRNA synthetase revealed by fragment-based crystallographic cocktail screens.

Authors:  Cho Yeow Koh; Latha Kallur Siddaramaiah; Ranae M Ranade; Jasmine Nguyen; Tengyue Jian; Zhongsheng Zhang; J Robert Gillespie; Frederick S Buckner; Christophe L M J Verlinde; Erkang Fan; Wim G J Hol
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-07-31

Review 9.  Fragment-based screening by protein crystallography: successes and pitfalls.

Authors:  Zorik Chilingaryan; Zhou Yin; Aaron J Oakley
Journal:  Int J Mol Sci       Date:  2012-10-08       Impact factor: 5.923

10.  Fragment Screening of Human Aquaporin 1.

Authors:  Janet To; Jaume Torres
Journal:  Int J Mol Sci       Date:  2016-03-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.